ScoreWhy is Bio-Rad Laboratories, Inc. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 2.18% over the last 5 years
2
The company has declared negative results in Mar'2025 after 3 consecutive positive quarters
- PRE-TAX PROFIT(Q) Lowest at USD 82 MM
- DEBT-EQUITY RATIO (HY) Highest at 0.43 %
- INVENTORY TURNOVER RATIO(HY) Lowest at 1.48 times
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -8.06%, its profits have risen by 69.4% ; the PEG ratio of the company is 0.1
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -8.06% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Bio-Rad Laboratories, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Bio-Rad Laboratories, Inc. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Bio-Rad Laboratories, Inc.
4.86%
0.24
43.70%
S&P 500
18.34%
0.70
20.15%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
0.29%
EBIT Growth (5y)
-8.37%
EBIT to Interest (avg)
30.77
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.06
Sales to Capital Employed (avg)
0.30
Tax Ratio
21.31%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
4.97%
ROE (avg)
11.09%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
21
Industry P/E
Price to Book Value
0.96
EV to EBIT
25.74
EV to EBITDA
14.49
EV to Capital Employed
0.95
EV to Sales
2.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.71%
ROE (Latest)
4.65%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 532.2 MM
ROCE(HY)
Highest at 10.84%
DEBTORS TURNOVER RATIO(HY)
Highest at 5.51 times
NET SALES(Q)
Highest at USD 693.2 MM
EPS(Q)
Highest at USD 26.65
-13What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 6.63% (YoY
OPERATING PROFIT MARGIN(Q)
Lowest at 16.49 %
NET PROFIT(Q)
Lowest at USD 62.38 MM
Here's what is working for Bio-Rad Laboratories, Inc.
Operating Cash Flow
Highest at USD 532.2 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 693.2 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
EPS
Highest at USD 26.65
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debtors Turnover Ratio
Highest at 5.51 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Bio-Rad Laboratories, Inc.
Net Profit
At USD 62.38 MM has Fallen at -56.31%
over average net sales of the previous four periods of USD 142.76 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Operating Profit Margin
Lowest at 16.49 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Net Profit
Lowest at USD 62.38 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Raw Material Cost
Grown by 6.63% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
